These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21557770)

  • 1. Biology of hepatic cancer stem cells.
    Tong CM; Ma S; Guan XY
    J Gastroenterol Hepatol; 2011 Aug; 26(8):1229-37. PubMed ID: 21557770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology and clinical implications of CD133(+) liver cancer stem cells.
    Ma S
    Exp Cell Res; 2013 Jan; 319(2):126-32. PubMed ID: 22999864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver cancer stem cells: implications for a new therapeutic target.
    Lee TK; Castilho A; Ma S; Ng IO
    Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.
    Chiba T; Kamiya A; Yokosuka O; Iwama A
    Cancer Lett; 2009 Dec; 286(2):145-53. PubMed ID: 19464789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma.
    Lee TK; Cheung VC; Ng IO
    Cancer Lett; 2013 Sep; 338(1):101-9. PubMed ID: 22579789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
    Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J
    Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma.
    Wu XZ; Xie GR; Chen D
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1178-82. PubMed ID: 17559361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.
    Schattenberg JM; Schuchmann M; Galle PR
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():213-9. PubMed ID: 21199533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive feedback loop between cancer stem cells and angiogenesis in hepatocellular carcinoma.
    Yao H; Liu N; Lin MC; Zheng J
    Cancer Lett; 2016 Sep; 379(2):213-9. PubMed ID: 27108065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.
    Muramatsu S; Tanaka S; Mogushi K; Adikrisna R; Aihara A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Nakayama K; Tanaka H; Yamaoka S; Arii S
    Hepatology; 2013 Jul; 58(1):218-28. PubMed ID: 23447025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular density and VEGF expression in hepatic lesions.
    Brodsky SV; Mendelev N; Melamed M; Ramaswamy G
    J Gastrointestin Liver Dis; 2007 Dec; 16(4):373-7. PubMed ID: 18193117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM.
    Tsuchiya A; Kamimura H; Tamura Y; Takamura M; Yamagiwa S; Suda T; Nomoto M; Aoyagi Y
    Cancer Lett; 2011 Oct; 309(1):95-103. PubMed ID: 21669487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.
    Chiba T; Kita K; Zheng YW; Yokosuka O; Saisho H; Iwama A; Nakauchi H; Taniguchi H
    Hepatology; 2006 Jul; 44(1):240-51. PubMed ID: 16799977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin.
    Inagaki Y; Tang W; Makuuchi M; Hasegawa K; Sugawara Y; Kokudo N
    Liver Int; 2011 Jan; 31(1):22-35. PubMed ID: 20874725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics for the early detection and treatment of hepatocellular carcinoma.
    Feng JT; Shang S; Beretta L
    Oncogene; 2006 Jun; 25(27):3810-7. PubMed ID: 16799622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular changes in hepatocellular carcinoma.
    Yang ZF; Poon RT
    Anat Rec (Hoboken); 2008 Jun; 291(6):721-34. PubMed ID: 18484619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel therapeutic strategies for treatment of hepatocellular carcinoma: targeting intervention on liver cancer stem cells].
    Li X; Luo Q; Song G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):894-8. PubMed ID: 24059077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shaping the future management of hepatocellular carcinoma.
    Abou-Alfa G; Colombo M
    Semin Liver Dis; 2013 Feb; 33 Suppl 1():S20-3. PubMed ID: 23457036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.